SCHEMBL24929004

SCHEMBL24929004

Cc1ccc(Cl)c2c1oc1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AHR P35869 5/20 0.46
MAOA P21397 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.40
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TTR P02766 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 1/20 0.37
CYP2A6 P11509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11743017 0.87 MAOA (0.56) MAOASMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL22377513 0.86 AHR (0.46) AHRMAOASMN1; SMN2ALDH1A1KMT2A
SCHEMBL14465618 0.85 MAPT (0.43) AHRMAOASMN1; SMN2MAPTALDH1A1
SCHEMBL16275891 0.79 LMNA (0.42) AHRMAOASMN1; SMN2MAPTALDH1A1
SCHEMBL22315997 0.79 CDC14B (0.51) AHRMAOASMN1; SMN2MAPTALDH1A1
SCHEMBL22892836 0.79 AHR (0.46) AHRMAOASMN1; SMN2MAPTALDH1A1
SCHEMBL21862042 0.79 AHR (0.46) AHRMAOASMN1; SMN2MAPTKMT2A
SCHEMBL30394680 0.79 CDC14B (0.51) AHRMAOASMN1; SMN2MAPTALDH1A1
SCHEMBL23176964 0.79 MAOA (0.40) MAOAMAPTALDH1A1KMT2AKDM4E
SCHEMBL16275924 0.79 CDC14B (0.44) AHRMAOASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023008795-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER 엘티소재주식회사 2023-02-02 WO disclosed